LinkedIn Profile

Access Alexion Pharmaceuticals historical Linkedin company profile data on number of followers, employee headcount and more

Records

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Ticker Sector Ticker Industry
nasdaq:alxn 16750 Apr 3rd, 2019 12:00AM Alexion Pharmaceuticals, Inc. 101K 2738 Open Biotechnology Apr 2nd, 2019 10:07PM Apr 2nd, 2019 10:07PM At Alexion, our mission is to serve patients and families affected by rare diseases. Since our founding, we have given hope to people who had none and shined a light on those who felt isolated and alone. But we know that fighting rare diseases takes so much more than hope. It requires persistence, dedication, and a relentless pursuit of the highest levels of medical innovation. At Alexion, our goal is to deliver medical breakthroughs where none currently exist. We have pioneered the complex field of complement biology and delivered solutions to challenges that once seemed impossible for patients with devastating complement-mediated and metabolic disorders. Patients are our Guiding Star, and they inspire us every day to continue to find answers to the most complex scientific challenges because we know lives are at stake. Alexion has 2,500 dedicated and passionate employees serving patients in 50 countries across the globe. Together, we are building a rewarding place to work and are redefining what it means to live with a rare disease. Our legacy will be measured in the families we serve today and the generations that follow. Our global headquarters are based in Boston, Massachusetts and our EMEA headquarters are in Zürich, Switzerland. We also have a Research Center of Excellence in New Haven, Connecticut, global supply chain and operations headquarters in Ireland, and local and regional operations in countries around the world. Open Biotechnology, Biopharmaceutical, Complement Inhibition, Metabolic Disorders, Neurology, Rare Diseases, Research and Development, hematology, nephrology Open 121 Seaport Blvd Boston Massachusetts US Health Care Pharmaceuticals & Biotechnology
nasdaq:alxn 16750 Apr 2nd, 2019 12:00AM Alexion Pharmaceuticals, Inc. 101K 2737 Open Biotechnology Apr 1st, 2019 10:06PM Apr 1st, 2019 10:06PM At Alexion, our mission is to serve patients and families affected by rare diseases. Since our founding, we have given hope to people who had none and shined a light on those who felt isolated and alone. But we know that fighting rare diseases takes so much more than hope. It requires persistence, dedication, and a relentless pursuit of the highest levels of medical innovation. At Alexion, our goal is to deliver medical breakthroughs where none currently exist. We have pioneered the complex field of complement biology and delivered solutions to challenges that once seemed impossible for patients with devastating complement-mediated and metabolic disorders. Patients are our Guiding Star, and they inspire us every day to continue to find answers to the most complex scientific challenges because we know lives are at stake. Alexion has 2,500 dedicated and passionate employees serving patients in 50 countries across the globe. Together, we are building a rewarding place to work and are redefining what it means to live with a rare disease. Our legacy will be measured in the families we serve today and the generations that follow. Our global headquarters are based in Boston, Massachusetts and our EMEA headquarters are in Zürich, Switzerland. We also have a Research Center of Excellence in New Haven, Connecticut, global supply chain and operations headquarters in Ireland, and local and regional operations in countries around the world. Open Biotechnology, Biopharmaceutical, Complement Inhibition, Metabolic Disorders, Neurology, Rare Diseases, Research and Development, hematology, nephrology Open 121 Seaport Blvd Boston Massachusetts US Health Care Pharmaceuticals & Biotechnology
nasdaq:alxn 16750 Apr 1st, 2019 12:00AM Alexion Pharmaceuticals, Inc. 101K 2741 Open Biotechnology Mar 31st, 2019 10:06PM Mar 31st, 2019 10:06PM At Alexion, our mission is to serve patients and families affected by rare diseases. Since our founding, we have given hope to people who had none and shined a light on those who felt isolated and alone. But we know that fighting rare diseases takes so much more than hope. It requires persistence, dedication, and a relentless pursuit of the highest levels of medical innovation. At Alexion, our goal is to deliver medical breakthroughs where none currently exist. We have pioneered the complex field of complement biology and delivered solutions to challenges that once seemed impossible for patients with devastating complement-mediated and metabolic disorders. Patients are our Guiding Star, and they inspire us every day to continue to find answers to the most complex scientific challenges because we know lives are at stake. Alexion has 2,500 dedicated and passionate employees serving patients in 50 countries across the globe. Together, we are building a rewarding place to work and are redefining what it means to live with a rare disease. Our legacy will be measured in the families we serve today and the generations that follow. Our global headquarters are based in Boston, Massachusetts and our EMEA headquarters are in Zürich, Switzerland. We also have a Research Center of Excellence in New Haven, Connecticut, global supply chain and operations headquarters in Ireland, and local and regional operations in countries around the world. Open Biotechnology, Biopharmaceutical, Complement Inhibition, Metabolic Disorders, Neurology, Rare Diseases, Research and Development, hematology, nephrology Open 121 Seaport Blvd Boston Massachusetts US Health Care Pharmaceuticals & Biotechnology
nasdaq:alxn 16750 Mar 31st, 2019 12:00AM Alexion Pharmaceuticals, Inc. 100K 2746 Open Biotechnology Mar 30th, 2019 10:06PM Mar 30th, 2019 10:06PM At Alexion, our mission is to serve patients and families affected by rare diseases. Since our founding, we have given hope to people who had none and shined a light on those who felt isolated and alone. But we know that fighting rare diseases takes so much more than hope. It requires persistence, dedication, and a relentless pursuit of the highest levels of medical innovation. At Alexion, our goal is to deliver medical breakthroughs where none currently exist. We have pioneered the complex field of complement biology and delivered solutions to challenges that once seemed impossible for patients with devastating complement-mediated and metabolic disorders. Patients are our Guiding Star, and they inspire us every day to continue to find answers to the most complex scientific challenges because we know lives are at stake. Alexion has 2,500 dedicated and passionate employees serving patients in 50 countries across the globe. Together, we are building a rewarding place to work and are redefining what it means to live with a rare disease. Our legacy will be measured in the families we serve today and the generations that follow. Our global headquarters are based in Boston, Massachusetts and our EMEA headquarters are in Zürich, Switzerland. We also have a Research Center of Excellence in New Haven, Connecticut, global supply chain and operations headquarters in Ireland, and local and regional operations in countries around the world. Open Biotechnology, Biopharmaceutical, Complement Inhibition, Metabolic Disorders, Neurology, Rare Diseases, Research and Development, hematology, nephrology Open 121 Seaport Blvd Boston Massachusetts US Health Care Pharmaceuticals & Biotechnology
nasdaq:alxn 16750 Mar 30th, 2019 12:00AM Alexion Pharmaceuticals, Inc. 100K 2737 Open Biotechnology Mar 29th, 2019 10:06PM Mar 29th, 2019 10:06PM At Alexion, our mission is to serve patients and families affected by rare diseases. Since our founding, we have given hope to people who had none and shined a light on those who felt isolated and alone. But we know that fighting rare diseases takes so much more than hope. It requires persistence, dedication, and a relentless pursuit of the highest levels of medical innovation. At Alexion, our goal is to deliver medical breakthroughs where none currently exist. We have pioneered the complex field of complement biology and delivered solutions to challenges that once seemed impossible for patients with devastating complement-mediated and metabolic disorders. Patients are our Guiding Star, and they inspire us every day to continue to find answers to the most complex scientific challenges because we know lives are at stake. Alexion has 2,500 dedicated and passionate employees serving patients in 50 countries across the globe. Together, we are building a rewarding place to work and are redefining what it means to live with a rare disease. Our legacy will be measured in the families we serve today and the generations that follow. Our global headquarters are based in Boston, Massachusetts and our EMEA headquarters are in Zürich, Switzerland. We also have a Research Center of Excellence in New Haven, Connecticut, global supply chain and operations headquarters in Ireland, and local and regional operations in countries around the world. Open Biotechnology, Biopharmaceutical, Complement Inhibition, Metabolic Disorders, Neurology, Rare Diseases, Research and Development, hematology, nephrology Open 121 Seaport Blvd Boston Massachusetts US Health Care Pharmaceuticals & Biotechnology
nasdaq:alxn 16750 Mar 29th, 2019 12:00AM Alexion Pharmaceuticals, Inc. 100K 2736 Open Biotechnology Mar 28th, 2019 10:06PM Mar 28th, 2019 10:06PM At Alexion, our mission is to serve patients and families affected by rare diseases. Since our founding, we have given hope to people who had none and shined a light on those who felt isolated and alone. But we know that fighting rare diseases takes so much more than hope. It requires persistence, dedication, and a relentless pursuit of the highest levels of medical innovation. At Alexion, our goal is to deliver medical breakthroughs where none currently exist. We have pioneered the complex field of complement biology and delivered solutions to challenges that once seemed impossible for patients with devastating complement-mediated and metabolic disorders. Patients are our Guiding Star, and they inspire us every day to continue to find answers to the most complex scientific challenges because we know lives are at stake. Alexion has 2,500 dedicated and passionate employees serving patients in 50 countries across the globe. Together, we are building a rewarding place to work and are redefining what it means to live with a rare disease. Our legacy will be measured in the families we serve today and the generations that follow. Our global headquarters are based in Boston, Massachusetts and our EMEA headquarters are in Zürich, Switzerland. We also have a Research Center of Excellence in New Haven, Connecticut, global supply chain and operations headquarters in Ireland, and local and regional operations in countries around the world. Open Biotechnology, Biopharmaceutical, Complement Inhibition, Metabolic Disorders, Neurology, Rare Diseases, Research and Development, hematology, nephrology Open 121 Seaport Blvd Boston Massachusetts US Health Care Pharmaceuticals & Biotechnology
nasdaq:alxn 16750 Mar 28th, 2019 12:00AM Alexion Pharmaceuticals, Inc. 100K 2740 Open Biotechnology Mar 27th, 2019 10:06PM Mar 27th, 2019 10:06PM At Alexion, our mission is to serve patients and families affected by rare diseases. Since our founding, we have given hope to people who had none and shined a light on those who felt isolated and alone. But we know that fighting rare diseases takes so much more than hope. It requires persistence, dedication, and a relentless pursuit of the highest levels of medical innovation. At Alexion, our goal is to deliver medical breakthroughs where none currently exist. We have pioneered the complex field of complement biology and delivered solutions to challenges that once seemed impossible for patients with devastating complement-mediated and metabolic disorders. Patients are our Guiding Star, and they inspire us every day to continue to find answers to the most complex scientific challenges because we know lives are at stake. Alexion has 2,500 dedicated and passionate employees serving patients in 50 countries across the globe. Together, we are building a rewarding place to work and are redefining what it means to live with a rare disease. Our legacy will be measured in the families we serve today and the generations that follow. Our global headquarters are based in Boston, Massachusetts and our EMEA headquarters are in Zürich, Switzerland. We also have a Research Center of Excellence in New Haven, Connecticut, global supply chain and operations headquarters in Ireland, and local and regional operations in countries around the world. Open Biotechnology, Biopharmaceutical, Complement Inhibition, Metabolic Disorders, Neurology, Rare Diseases, Research and Development, hematology, nephrology Open 121 Seaport Blvd Boston Massachusetts US Health Care Pharmaceuticals & Biotechnology
nasdaq:alxn 16750 Mar 27th, 2019 12:00AM Alexion Pharmaceuticals, Inc. 100K 2738 Open Biotechnology Mar 26th, 2019 10:07PM Mar 26th, 2019 10:07PM At Alexion, our mission is to serve patients and families affected by rare diseases. Since our founding, we have given hope to people who had none and shined a light on those who felt isolated and alone. But we know that fighting rare diseases takes so much more than hope. It requires persistence, dedication, and a relentless pursuit of the highest levels of medical innovation. At Alexion, our goal is to deliver medical breakthroughs where none currently exist. We have pioneered the complex field of complement biology and delivered solutions to challenges that once seemed impossible for patients with devastating complement-mediated and metabolic disorders. Patients are our Guiding Star, and they inspire us every day to continue to find answers to the most complex scientific challenges because we know lives are at stake. Alexion has 2,500 dedicated and passionate employees serving patients in 50 countries across the globe. Together, we are building a rewarding place to work and are redefining what it means to live with a rare disease. Our legacy will be measured in the families we serve today and the generations that follow. Our global headquarters are based in Boston, Massachusetts and our EMEA headquarters are in Zürich, Switzerland. We also have a Research Center of Excellence in New Haven, Connecticut, global supply chain and operations headquarters in Ireland, and local and regional operations in countries around the world. Open Biotechnology, Biopharmaceutical, Complement Inhibition, Metabolic Disorders, Neurology, Rare Diseases, Research and Development, hematology, nephrology Open 121 Seaport Blvd Boston Massachusetts US Health Care Pharmaceuticals & Biotechnology
nasdaq:alxn 16750 Mar 26th, 2019 12:00AM Alexion Pharmaceuticals, Inc. 100K 2737 Open Biotechnology Mar 25th, 2019 10:06PM Mar 25th, 2019 10:06PM At Alexion, our mission is to serve patients and families affected by rare diseases. Since our founding, we have given hope to people who had none and shined a light on those who felt isolated and alone. But we know that fighting rare diseases takes so much more than hope. It requires persistence, dedication, and a relentless pursuit of the highest levels of medical innovation. At Alexion, our goal is to deliver medical breakthroughs where none currently exist. We have pioneered the complex field of complement biology and delivered solutions to challenges that once seemed impossible for patients with devastating complement-mediated and metabolic disorders. Patients are our Guiding Star, and they inspire us every day to continue to find answers to the most complex scientific challenges because we know lives are at stake. Alexion has 2,500 dedicated and passionate employees serving patients in 50 countries across the globe. Together, we are building a rewarding place to work and are redefining what it means to live with a rare disease. Our legacy will be measured in the families we serve today and the generations that follow. Our global headquarters are based in Boston, Massachusetts and our EMEA headquarters are in Zürich, Switzerland. We also have a Research Center of Excellence in New Haven, Connecticut, global supply chain and operations headquarters in Ireland, and local and regional operations in countries around the world. Open Biotechnology, Biopharmaceutical, Complement Inhibition, Metabolic Disorders, Neurology, Rare Diseases, Research and Development, hematology, nephrology Open 121 Seaport Blvd Boston Massachusetts US Health Care Pharmaceuticals & Biotechnology
nasdaq:alxn 16750 Mar 25th, 2019 12:00AM Alexion Pharmaceuticals, Inc. 99K 2737 Open Biotechnology Mar 24th, 2019 10:06PM Mar 24th, 2019 10:06PM At Alexion, our mission is to serve patients and families affected by rare diseases. Since our founding, we have given hope to people who had none and shined a light on those who felt isolated and alone. But we know that fighting rare diseases takes so much more than hope. It requires persistence, dedication, and a relentless pursuit of the highest levels of medical innovation. At Alexion, our goal is to deliver medical breakthroughs where none currently exist. We have pioneered the complex field of complement biology and delivered solutions to challenges that once seemed impossible for patients with devastating complement-mediated and metabolic disorders. Patients are our Guiding Star, and they inspire us every day to continue to find answers to the most complex scientific challenges because we know lives are at stake. Alexion has 2,500 dedicated and passionate employees serving patients in 50 countries across the globe. Together, we are building a rewarding place to work and are redefining what it means to live with a rare disease. Our legacy will be measured in the families we serve today and the generations that follow. Our global headquarters are based in Boston, Massachusetts and our EMEA headquarters are in Zürich, Switzerland. We also have a Research Center of Excellence in New Haven, Connecticut, global supply chain and operations headquarters in Ireland, and local and regional operations in countries around the world. Open Biotechnology, Biopharmaceutical, Complement Inhibition, Metabolic Disorders, Neurology, Rare Diseases, Research and Development, hematology, nephrology Open 121 Seaport Blvd Boston Massachusetts US Health Care Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.